Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 1, 2008. The report details a specific corporate action regarding the repurchase and cancellation of the company's own ordinary shares, executed in accordance with shareholder authority granted at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital movements.
- Shares Repurchased: 800,000 ordinary shares.
- Repurchase Price: 1,127.77 pence per share.
- Treasury Shares Held: 484,194,158 shares (representing 9.00% of total voting rights).
- Shares in Issue: 5,377,246,676 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of the company's share capital through the cancellation of 800,000 repurchased shares. Consequently, the total number of shares held in Treasury has increased to 484,194,158. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer stating that the announcement does not constitute an offer or solicitation to purchase securities and confirms conformity with the Financial Services Authority's Disclosure and Transparency Rules. No specific risks or contingencies are detailed in this document.
Key Facts for Investor Verification
- Verify the total cost of the share repurchase (800,000 shares at 1,127.77 pence each).
- Confirm the updated percentage of Treasury shares relative to total voting rights (9.00%).
- Check the current number of shares in issue (5,377,246,676) for accurate calculation of ownership thresholds under Disclosure and Transparency Rules.
- Note that this filing does not contain financial results; refer to Form 20-F or quarterly reports for revenue and earnings data.